{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T01:08:41Z","timestamp":1773104921813,"version":"3.50.1"},"reference-count":43,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,5]],"date-time":"2022-03-05T00:00:00Z","timestamp":1646438400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jscai.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Society for Cardiovascular Angiography & Interventions"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.jscai.2022.100040","type":"journal-article","created":{"date-parts":[[2022,5,19]],"date-time":"2022-05-19T04:03:46Z","timestamp":1652933026000},"page":"100040","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["SCAI Technical Review on Management of Patent Foramen Ovale"],"prefix":"10.1016","volume":"1","author":[{"given":"Andrew M.","family":"Goldsweig","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarosh P.","family":"Batlivala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karim","family":"Al-Azizi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vikas","family":"Aggarwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ifeoluwa","family":"Babatunde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yngve","family":"Falck-Ytter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca L.","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jscai.2022.100040_bib1","doi-asserted-by":"crossref","first-page":"281","DOI":"10.3389\/fneur.2020.00281","article-title":"Epidemiology of patent foramen ovale in general population and in stroke patients: a narrative review","volume":"11","author":"Koutroulou","year":"2020","journal-title":"Front Neurol"},{"issue":"20","key":"10.1016\/j.jscai.2022.100040_bib2","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1016\/j.jacc.2018.02.046","article-title":"Cryptogenic stroke and high-risk patent foramen ovale","volume":"71","author":"Lee","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"11","key":"10.1016\/j.jscai.2022.100040_bib3","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1056\/NEJMoa1705915","article-title":"Patent foramen ovale closure or anticoagulation vs. antiplatelets after stroke","volume":"377","author":"Mas","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"11","key":"10.1016\/j.jscai.2022.100040_bib4","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1056\/NEJMoa1610057","article-title":"Long-term outcomes of patent foramen ovale closure or medical therapy after stroke","volume":"377","author":"Saver","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"11","key":"10.1016\/j.jscai.2022.100040_bib5","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1056\/NEJMoa1707404","article-title":"Patent foramen ovale closure or antiplatelet therapy for cryptogenic stroke","volume":"377","author":"S\u00f8ndergaard","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"16","key":"10.1016\/j.jscai.2022.100040_bib6","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1093\/eurheartj\/ehaa1070","article-title":"European position paper on the management of patients with patent foramen ovale. Part II - decompression sickness, migraine, arterial deoxygenation syndromes and select high-risk clinical conditions","volume":"42","author":"Pristipino","year":"2021","journal-title":"Eur Heart J"},{"issue":"38","key":"10.1016\/j.jscai.2022.100040_bib7","doi-asserted-by":"crossref","first-page":"3182","DOI":"10.1093\/eurheartj\/ehy649","article-title":"European position paper on the management of patients with patent foramen ovale. General approach and left circulation thromboembolism","volume":"40","author":"Pristipino","year":"2018","journal-title":"Eur Heart J"},{"issue":"20","key":"10.1016\/j.jscai.2022.100040_bib8","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1212\/WNL.0000000000009443","article-title":"Practice advisory update summary: patent foramen ovale and secondary stroke prevention","volume":"94","author":"Mess\u00e9","year":"2020","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.jscai.2022.100040_bib9","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jclinepi.2010.07.015","article-title":"GRADE guidelines: 3. Rating the quality of evidence","volume":"64","author":"Balshem","year":"2011","journal-title":"J\u00a0Clin Epidemiol"},{"issue":"4","key":"10.1016\/j.jscai.2022.100040_bib10","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction\u2014GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"J\u00a0Clin Epidemiol"},{"issue":"4","key":"10.1016\/j.jscai.2022.100040_bib11","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jclinepi.2010.09.012","article-title":"GRADE guidelines: 2. Framing the question and deciding on important outcomes","volume":"64","author":"Guyatt","year":"2011","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.jscai.2022.100040_bib12","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.jscai.2022.100040_bib13","doi-asserted-by":"crossref","first-page":"i4919","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.jscai.2022.100040_bib14","series-title":"Cochrane Handbook for Systematic Reviews of Interventions","first-page":"143","article-title":"Choosing effect measures and computing estimates of effect","author":"Higgins","year":"2019"},{"issue":"2","key":"10.1016\/j.jscai.2022.100040_bib15","doi-asserted-by":"crossref","first-page":"80","DOI":"10.28920\/dhm49.2.80-87","article-title":"The effectiveness of risk mitigation interventions in divers with persistent (patent) foramen ovale","volume":"49","author":"Anderson","year":"2019","journal-title":"Diving Hyperb Med"},{"issue":"3","key":"10.1016\/j.jscai.2022.100040_bib16","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1159\/000512184","article-title":"Patent foramen ovale closure among patients with hypercoagulable states maintained on antithrombotic therapy","volume":"146","author":"Buber","year":"2021","journal-title":"Cardiology"},{"issue":"11","key":"10.1016\/j.jscai.2022.100040_bib17","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1161\/CIRCULATIONAHA.107.727271","article-title":"Migraine Intervention with STARFlex Technology (MIST) trial","volume":"117","author":"Dowson","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.jscai.2022.100040_bib18","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.3389\/fneur.2019.01224","article-title":"Transcatheter patent foramen ovale closure is effective in alleviating migraine in a 5-year follow-up","volume":"10","author":"He","year":"2019","journal-title":"Front Neurol"},{"issue":"1","key":"10.1016\/j.jscai.2022.100040_bib19","doi-asserted-by":"crossref","first-page":"153","DOI":"10.5603\/KP.a2017.0182","article-title":"Transcatheter closure of patent foramen ovale for the secondary prevention of decompression illness in professional divers: a single-centre experience with long-term follow-up","volume":"76","author":"Henzel","year":"2018","journal-title":"Kardiol Pol"},{"issue":"11","key":"10.1016\/j.jscai.2022.100040_bib20","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s12471-018-1153-x","article-title":"Persistent foramen ovale closure in divers with a history of decompression sickness","volume":"26","author":"Koopsen","year":"2018","journal-title":"Neth Heart J"},{"issue":"26","key":"10.1016\/j.jscai.2022.100040_bib21","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1093\/eurheartj\/ehw027","article-title":"Percutaneous closure of patent foramen ovale in migraine with aura, a randomized controlled trial","volume":"37","author":"Mattle","year":"2016","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.jscai.2022.100040_bib22","first-page":"701","article-title":"The effect of patent foramen ovale closure in patients with platypnea-orthodeoxia syndrome","volume":"86","author":"Mojadidi","year":"2015","journal-title":"Catheter Cardiovasc Interv"},{"issue":"10","key":"10.1016\/j.jscai.2022.100040_bib23","first-page":"510","article-title":"Gore Helex septal occluder for percutaneous closure of patent foramen ovale associated with atrial septal aneurysm: short- and mid-term clinical and echocardiographic outcomes","volume":"24","author":"Musto","year":"2012","journal-title":"J\u00a0Invasive Cardiol"},{"issue":"6","key":"10.1016\/j.jscai.2022.100040_bib24","doi-asserted-by":"crossref","first-page":"357","DOI":"10.3109\/14017431.2015.1071874","article-title":"Closure of a patent foramen ovale in patients with platypnoea-orthodeoxia: a rare and overlooked cause of dyspnoea and hypoxaemia","volume":"49","author":"Pedersen","year":"2015","journal-title":"Scand Cardiovasc J"},{"issue":"18","key":"10.1016\/j.jscai.2022.100040_bib25","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1016\/j.jcin.2016.07.003","article-title":"Percutaneous intervention to treat Platypnea-Orthodeoxia syndrome: the Toronto experience","volume":"9","author":"Shah","year":"2016","journal-title":"JACC Cardiovasc Interv"},{"issue":"22","key":"10.1016\/j.jscai.2022.100040_bib26","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.1016\/j.jacc.2017.09.1105","article-title":"Percutaneous closure of patent foramen ovale in patients with migraine","volume":"70","author":"Tobis","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.jscai.2022.100040_bib27","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.jacc.2018.10.061","article-title":"Long-term follow-up after closure of patent foramen ovale in patients with cryptogenic embolism","volume":"73","author":"Wintzer-Wehekind","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.jscai.2022.100040_bib28","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.recesp.2019.07.009","article-title":"Transcatheter closure of patent foramen ovale in patients older than 60 years of age with cryptogenic embolism","volume":"73","author":"Wintzer-Wehekind","year":"2020","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"issue":"12","key":"10.1016\/j.jscai.2022.100040_bib29","article-title":"Patent foramen ovale closure for stroke prevention and other disorders","volume":"7","author":"Collado","year":"2018","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"9","key":"10.1016\/j.jscai.2022.100040_bib30","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.jacc.2020.06.072","article-title":"Patent foramen ovale closure is effective in divers: long-term results from the DIVE-PFO registry","volume":"76","author":"Hon\u011bk","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.jscai.2022.100040_bib31","first-page":"64","article-title":"Platypnea-orthodeoxia syndrome: etiology, differential diagnosis, and management","volume":"47","author":"Cheng","year":"1999","journal-title":"Catheter Cardiovasc Interv"},{"issue":"23","key":"10.1016\/j.jscai.2022.100040_bib32","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1016\/j.jcin.2020.09.059","article-title":"Patent foramen ovale attributable cryptogenic embolism with thrombophilia has higher risk for recurrence and responds to closure","volume":"13","author":"Liu","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jscai.2022.100040_bib33","doi-asserted-by":"crossref","first-page":"9849425","DOI":"10.1155\/2017\/9849425","article-title":"Recurrent stroke after transcatheter PFO closure in cryptogenic stroke or TIA: long-term follow-up","volume":"2017","author":"Mariucci","year":"2017","journal-title":"Cardiol Res Pract"},{"issue":"5","key":"10.1016\/j.jscai.2022.100040_bib34","doi-asserted-by":"crossref","first-page":"290","DOI":"10.2459\/JCM.0000000000000790","article-title":"Insertable cardiac monitor detection of silent atrial fibrillation in candidates for percutaneous patent foramen ovale closure","volume":"20","author":"Scacciatella","year":"2019","journal-title":"J\u00a0Cardiovasc Med (Hagerstown)"},{"issue":"3","key":"10.1016\/j.jscai.2022.100040_bib35","first-page":"508","article-title":"Recurrent cerebral ischemia after patent foramen ovale percutaneous closure in older patients: a two-center registry study","volume":"87","author":"Scacciatella","year":"2016","journal-title":"Catheter Cardiovasc Interv"},{"issue":"10","key":"10.1016\/j.jscai.2022.100040_bib36","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1007\/s00380-019-01379-0","article-title":"Percutaneous transcatheter closure of high-risk patent foramen ovale in the elderly","volume":"34","author":"Takafuji","year":"2019","journal-title":"Heart Vessels"},{"issue":"12","key":"10.1016\/j.jscai.2022.100040_bib37","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/S1474-4422(18)30319-3","article-title":"Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial","volume":"17","author":"Kasner","year":"2018","journal-title":"Lancet Neurol"},{"issue":"13","key":"10.1016\/j.jscai.2022.100040_bib38","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1001\/archinte.165.13.1527","article-title":"Risks of oral anticoagulant therapy with increasing age","volume":"165","author":"Torn","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jscai.2022.100040_bib39","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ijcard.2017.07.058","article-title":"Occlutech percutaneous patent foramen ovale closure: safety and efficacy registry (OPPOSE)","volume":"245","author":"Hildick-Smith","year":"2017","journal-title":"Int J Cardiol"},{"issue":"1","key":"10.1016\/j.jscai.2022.100040_bib40","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2016-000475","article-title":"Percutaneous PFO closure for cryptogenic stroke in the setting of a systematic cardiac and neurological screening and a standardised follow-up protocol","volume":"4","author":"Noble","year":"2017","journal-title":"Open Heart"},{"issue":"3","key":"10.1016\/j.jscai.2022.100040_bib41","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/joic.12430","article-title":"Effect of patent foramen ovale closure for prevention on recurrent stroke or transient ischemic attack in selected patients with cryptogenic stroke","volume":"31","author":"Kim","year":"2018","journal-title":"J\u00a0Interv Cardiol"},{"issue":"9","key":"10.1016\/j.jscai.2022.100040_bib42","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.115.003470","article-title":"Propensity score\u2013based analysis of percutaneous closure versus medical therapy in patients with cryptogenic stroke and patent foramen ovale","volume":"9","author":"Pezzini","year":"2016","journal-title":"Circ Cardiovasc Interv"},{"issue":"4","key":"10.1016\/j.jscai.2022.100040_bib43","doi-asserted-by":"crossref","first-page":"317","DOI":"10.3109\/09537104.2015.1096335","article-title":"Antiplatelet effects of clopidogrel and aspirin after interventional patent foramen ovale\/atrium septum defect closure","volume":"27","author":"Polzin","year":"2016","journal-title":"Platelets"}],"updated-by":[{"DOI":"10.1016\/j.jscai.2022.100522","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000}}],"container-title":["Journal of the Society for Cardiovascular Angiography & Interventions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772930322000242?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772930322000242?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T13:32:11Z","timestamp":1757424731000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772930322000242"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S2772930322000242"],"URL":"https:\/\/doi.org\/10.1016\/j.jscai.2022.100040","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.jscai.2022.100522","asserted-by":"object"}]},"ISSN":["2772-9303"],"issn-type":[{"value":"2772-9303","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SCAI Technical Review on Management of Patent Foramen Ovale","name":"articletitle","label":"Article Title"},{"value":"Journal of the Society for Cardiovascular Angiography & Interventions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jscai.2022.100040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc. on behalf of the Society for Cardiovascular Angiography and Interventions Foundation.","name":"copyright","label":"Copyright"}],"article-number":"100040"}}